-+ 0.00%
-+ 0.00%
-+ 0.00%

ASCLETIS PHARMA INC. - FDA IND SUBMISSION OF ASC39, AN ORAL- SMALL MOLECULE SELECTIVE AMYLIN RECEPTOR AGONIST FOR- TREATMENT OF OBESITY

Reuters·10/26/2026 00:01:50

Please log in to view news